AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX
7 registrations across 4 African markets— 5 active
Markets with IRON (III) HYDROXIDE POLYMALTOSE COMPLEX
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AGIFER-X SYRUP Syrup | 🇰🇪Kenya | Agio Pharmaceticals Limited | active | Jun 2031 |
| SAFERON SYRUP; ORAL | 🇿🇼Zimbabwe | GLENMARK PHARMACEUTICALS LTD | active | Sept 2030 |
| OROFER SYRUP; ORAL | 🇿🇼Zimbabwe | EMCURE PHARMACEUTICALS LTD | active | Dec 2027 |
| FEROWIN SYRUP | 🇬🇭Ghana | — | active | Dec 2026 |
| FEROWIN SYRUP | 🇬🇭Ghana | — | active | Dec 2026 |
| NOVATONIC 50MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Mar 2025 |
| SAFERON 50MG/ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Jun 2017 |
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX in Africa — Regulatory Overview
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Zimbabwe, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.